Paras Healthcare IPO delivers: ₹40 crore Q2 profit vs ₹12 crore year-ago
Paras Healthcare's first post-listing quarterly results came in decisively ahead of the year-ago period: PAT ₹40.35 crore vs ₹12.38 crore, revenue ₹510.89 crore, with operating expenses well-controlled at ₹463 crore. The turnaround validates the IPO thesis — a mid-cap healthcare name with scalable hospital operations and an improving EBITDA trajectory. For India-focused healthcare investors, Paras sits at the intersection of two structural trends: domestic healthcare spend and second-tier city hospital capacity. Watch operating leverage as occupancy improves through Q3.
Read at Economic Times Markets ↗